Stay informed. Stay prepared.

Pharmacy Benefit Managers (PBMs) act as intermediaries between health systems, pharmacies, and drug manufacturers, intended to control drug costs through negotiated discounts. However, misaligned…

Data sovereignty in 340B programs refers to the ability of healthcare covered entities to maintain absolute control, privacy, and ownership over their patient and…

340B eligibility requirements for covered entities are designed to ensure that only specific healthcare providers serving vulnerable populations can access discounted drugs. To qualify,…

The 340B Drug Pricing Program is a U.S. federal program that allows eligible healthcare organizations to purchase outpatient drugs at significantly reduced prices. Because…

The shift in 2026 pharmacy benefits, driven by reforms under the Consolidated Appropriations Act, is tightening oversight on Pharmacy Benefit Managers (PBMs) through stronger…

What Is the DSH Calculation Trap and Why Does It Matter? The DSH calculation trap refers to the high-risk scenario where minor errors or…